Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02064946 · ClinicalTrials.gov registry record · NA
High-dose Vitamin D Supplementation for ADT-induced Side Effects
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT02064946 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 108 participants.
The verdict
NCT02064946, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy of a high-dose vitamin D supplementation regimen in reducing androgen deprivation therapy (ADT)-related side effects in older prostate cancer patients on ADT. The proposed study is a randomized, double-blind, 2-arm, controlled clinical trial that will accrue 76 prostate cancer patients without severe bone loss, aged 60 and older, beginning ADT, and scheduled to receive at least 6 months more of ADT. Participants will be randomized to: 1) weekly high-dose vitamin D3 (50,000 IU) or 2) vitamin D placebo only for a period of 24 weeks. Both groups will also receive a daily multivitamin and calcium supplement.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02064946
The ClinicalTrials.gov registry entry for NCT02064946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02064946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02064946 about?
NCT02064946 is a clinical study titled "High-dose Vitamin D Supplementation for ADT-induced Side Effects". The purpose of this study is to test the efficacy of a high-dose vitamin D supplementation regimen in reducing androgen deprivation therapy (ADT)-related side effects in older prostate cancer patients on ADT. The proposed study is a randomized, double-blind, 2-arm, controlled clinical trial that wil...
What is the current status of trial NCT02064946?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2014-03. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02064946?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02064946?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.